Intragastric Balloons in the Management of Obesity
Publication Date: April 1, 2021
Recommendations
1. In individuals with obesity seeking a weight-loss intervention who have failed a trial of conventional weight-loss strategies, AGA suggests the use of IGB therapy with lifestyle modification over lifestyle modification alone. ( Moderate , Conditional (weak) )
612
2. In individuals with obesity undergoing IGB therapy, AGA recommends moderate- to high-intensity concomitant lifestyle modification interventions to maintain and augment weight loss. ( Moderate , Strong )
612
3. In individuals undergoing IGB therapy, AGA recommends prophylaxis with PPIs. ( Moderate , Strong )
612
4. In individuals undergoing IGB therapy, AGA suggests using the intraoperative anesthetic regimens associated with the lowest incidence of nausea along with perioperative antiemetics. AGA suggests a scheduled antiemetic regimen for 2 week after IGB placement. ( Low , Conditional (weak) )
612
5. In individuals undergoing IGB therapy, AGA suggests against perioperative laboratory screening for nutritional deficiencies. ( Low , Conditional (weak) )
612
6. AGA suggests daily supplementation with 1–2 adult dose multivitamins after IGB placement. ( Very Low , Conditional (weak) )
612
7. After IGB removal, AGA suggests subsequent weight-loss or maintenance interventions that include dietary interventions, pharmacotherapy, repeat IGB, or bariatric surgery. The choice of weight-loss or maintenance method after IGB is determined based on patient’s context and comorbidities following a shared decision-making approach. ( Low , Conditional (weak) )
612
Recommendation Grading
Disclaimer
Overview
Title
Intragastric Balloons in the Management of Obesity
Authoring Organization
American Gastroenterological Association
Publication Month/Year
April 1, 2021
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Inclusion Criteria
Female, Male, Adult
Health Care Settings
Ambulatory, Hospital, Outpatient
Intended Users
Physician, nurse practitioner, nurse, physician assistant
Scope
Management
Diseases/Conditions (MeSH)
D009765 - Obesity
Keywords
obesity, Clinical Practice Guidelines, Intragastric Balloons, Endoscopic bariatric therapies